Tag Archives: regulatory
Drugs Approved Faster in US, Cost More
According to a study by the Tufts Center for the Study of Drug Development, more cancer drugs were approved in the US than in the EU during the 2010-2011 time … Continue reading
Posted in News
Also tagged cancer treatment, cost of care, insurance, medicare, outcomes, ovarian cancer, Research, risk, treatment
Leave a comment
FDA panel advises caution on personal genetic testing
An FDA advisory panel recommended that medical professionals be available to help patients undergoing personal, at-home, genetic testing. Doubts remain as to the usefulness of many of these tests, however … Continue reading
DNA Dilemma: The Full Interview With the FDA on DTC Genetic Tests (Newsweek)
In an interview yesterday, the FDA made some potentially controversial and confusing statements about consumer genetics, an area it’s in the process of deciding how to regulate. I criticize the … Continue reading
